Keywords: b-ms, acquires, license, bristol-myers, squibb, licensed, ultrasound

B-MS ACQUIRES LICENSE

Article | 22 March 1993

Print This

- Bristol-Myers Squibb has licensed the ultrasound contrast agent SonoRx (simethicone-coated cellulose) from USA-based ImRx Pharmaceuticals.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in